NYSE · CIK 0000002186
BKTI BK Technologies Corp
Insider trading from SEC Form 4. Last filing Jun 12, 2026. Close $73.52 on Oct 9, 2026, +18% from the 52-week low and -24% from the high.
BK Technologies Corp (BKTI) has 26 SEC Form 4 filings on file from 9 insiders, the latest filed on Jun 12, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
6 open-market trades have been scored at BKTI. The newest: John M Suzuki (CEO & President) sold $248k of stock on Jun 11, 2026, filed Jun 12, 2026, scored 38 (weak). The largest of the 6 shown: Branko Avanic (CTO) sold $277k on Sep 5, 2025, scored 54 (moderate). 3 insiders sold within 14 days of each other around Sep 5, 2025.
BKTI closed at $73.52 on Oct 9, 2026, 18% above its 52-week low and 24% below its 52-week high.
2 Form 144 notices of planned sales are on file, the latest filed Sep 8, 2025.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at BK Technologies Corp, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | John M Suzuki CEO & President sell | $248k 3,000 shares | -7% | +125% from low-13% from high | |
| 54Moderate | Branko Avanic CTO sell | $277k 4,031 shares | -27% | +237% from low-9% from high | |
| 30Weak | Ellen O OHara director sell | $7,172 100 shares | -5% | +254% from low-4% from high | |
| 52Moderate | John M Suzuki CEO & President sell | $210k 3,000 shares | -7% | +270% from low0% from high | |
| 28Weak | Ellen O OHara director sell | $19k 300 shares | -12% | +243% from low0% from high | |
| 42Moderate | Charles T Lanktree director sell | $55k 1,541 shares | -100% | - |
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Sep 8, 2025 | BK Technologies Corp OTHER | 2,000 0.05% of outstanding | $133k | Sep 8, 2025 | none |
| Aug 19, 2025 | Suzuki John M Officer | 2,000 0.05% of outstanding | $117k | Aug 19, 2025 | none |
Transactions
Every row filed, 48 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | John M Suzuki CEO & President | SOpen-market sale Common Stock | -2,000 | $81.61 | $163k | 40,896 | Jun 12, 2026 |
| Jun 11, 2026 | John M Suzuki CEO & President | SOpen-market sale Common Stock | -777 | $85.00 | $66k | 40,119 | Jun 12, 2026 |
| Jun 12, 2026 | John M Suzuki CEO & President | SOpen-market sale Common Stock | -223 | $85.02 | $19k | 39,896 | Jun 12, 2026 |
| Feb 2, 2026 | Branko Avanic CTO | AGrant or award Common Stock | +497 | $0.00 | $0 | 11,466 | Feb 4, 2026 |
| Jan 26, 2026 | Lloyd Roberts Sams director | AGrant or award Common Stock | +461 | $0.00 | $0 | 21,603 | Jan 27, 2026 |
| Jan 26, 2026 | E. Gray Payne director | AGrant or award Common Stock | +461 | $0.00 | $0 | 32,252 | Jan 27, 2026 |
| Jan 26, 2026 | Ellen O OHara director | AGrant or award Common Stock | +461 | $0.00 | $0 | 2,501 | Jan 27, 2026 |
| Jan 26, 2026 | Charles T Lanktree director | AGrant or award Common Stock | +461 | $0.00 | $0 | 30,920 | Jan 27, 2026 |
| Jan 26, 2026 | Robert Joseph Jackson director | AGrant or award Common Stock | +461 | $0.00 | $0 | 20,554 | Jan 27, 2026 |
| Jan 26, 2026 | Joshua Horowitz director | AGrant or award Common Stock | +461 | $0.00 | $0 | 28,461 | Jan 27, 2026 |
| Nov 13, 2025 | Scott A. Malmanger CFO & Secretary | MOption exercise Common Stock | +1,000 | $12.27 | $12k | 14,302 | Nov 13, 2025 |
| Nov 13, 2025 | Scott A. Malmanger CFO & Secretary | MOption exercise Stock Option (Right to Buy)derivative | -1,000 | $0.00 | $0 | 24,000 | Nov 13, 2025 |
| Sep 5, 2025 | Branko Avanic CTO | SOpen-market sale Common Stock | -2,031 | $68.89 | $140k | 12,969 | Sep 9, 2025 |
| Sep 8, 2025 | Branko Avanic CTO | SOpen-market sale Common Stock | -1,921 | $68.38 | $131k | 11,048 | Sep 9, 2025 |
| Sep 8, 2025 | Branko Avanic CTO | SOpen-market sale Common Stock | -79 | $69.14 | $5,462 | 10,969 | Sep 9, 2025 |
| Aug 28, 2025 | Ellen O OHara director | SOpen-market sale Common Stock | -100 | $71.72 | $7,172 | 2,040 | Aug 28, 2025 |
| Aug 22, 2025 | John M Suzuki CEO & President | SOpen-market sale Common Stock | -3,000 | $70.00 | $210k | 42,896 | Aug 22, 2025 |
| Aug 19, 2025 | Ellen O OHara director | SOpen-market sale Common Stock | -300 | $64.11 | $19k | 2,140 | Aug 19, 2025 |
| Jun 9, 2025 | Scott A. Malmanger CFO & Secretary | MOption exercise Common Stock | +5,000 | $12.27 | $61k | 13,302 | Jul 14, 2025 |
| Jul 10, 2025 | Scott A. Malmanger CFO & Secretary | AGrant or award Stock Option (Right to Buy)derivative | +50,175 | $0.00 | $0 | 50,175 | Jul 14, 2025 |
| Jul 10, 2025 | John M Suzuki CEO & President | AGrant or award Stock Option (Right to Buy)derivative | +112,391 | $0.00 | $0 | 112,391 | Jul 14, 2025 |
| Jun 9, 2025 | Scott A. Malmanger CFO & Secretary | MOption exercise Stock Option (Right to Buy)derivative | -5,000 | $0.00 | $0 | 25,000 | Jul 14, 2025 |
| Jun 23, 2023 | Branko Avanic CTO | AGrant or award Common Stock | +15,000 | $0.00 | $0 | 15,000 | Jun 25, 2025 |
| Nov 20, 2024 | Scott A. Malmanger CFO and Secretary | MOption exercise Common Stock | +1,000 | $15.53 | $16k | 8,302 | Mar 31, 2025 |
| Jul 11, 2023 | Scott A. Malmanger CFO and Secretary | AGrant or award Stock Option (Right to Buy)derivative | +5,000 | $0.00 | $0 | 5,000 | Mar 31, 2025 |
| Nov 20, 2024 | Scott A. Malmanger CFO and Secretary | MOption exercise Stock Option (Right to Buy)derivative | -1,000 | $0.00 | $0 | 4,000 | Mar 31, 2025 |
| Aug 21, 2023 | Robert Joseph Jackson director | AGrant or award Common Stock | +3,941 | $0.00 | $0 | 15,586 | Mar 20, 2025 |
| Aug 21, 2023 | Robert Joseph Jackson director | AGrant or award Common Stock | +3,234 | $0.00 | $0 | 18,820 | Mar 20, 2025 |
| Dec 14, 2023 | Robert Joseph Jackson director | AGrant or award Common Stock | +1,273 | $0.00 | $0 | 20,093 | Mar 20, 2025 |
| Jan 16, 2025 | Robert Joseph Jackson director | AGrant or award Stock Option (Right to Buy)derivative | +2,238 | $0.00 | $0 | 2,238 | Mar 20, 2025 |
| Aug 21, 2023 | E. Gray Payne director | AGrant or award Common Stock | +4,487 | $0.00 | $0 | 27,142 | Mar 17, 2025 |
| Aug 21, 2023 | Charles T Lanktree director | AGrant or award Common Stock | +3,395 | $0.00 | $0 | 26,093 | Mar 17, 2025 |
| Aug 21, 2023 | Lloyd Roberts Sams director | AGrant or award Common Stock | +3,213 | $0.00 | $0 | 16,837 | Mar 17, 2025 |
| Aug 21, 2023 | E. Gray Payne director | AGrant or award Common Stock | +3,234 | $0.00 | $0 | 30,376 | Mar 17, 2025 |
| Aug 21, 2023 | Lloyd Roberts Sams director | AGrant or award Common Stock | +3,234 | $0.00 | $0 | 20,071 | Mar 17, 2025 |
| Aug 21, 2023 | Charles T Lanktree director | AGrant or award Common Stock | +3,234 | $0.00 | $0 | 29,327 | Mar 17, 2025 |
| Dec 14, 2023 | Charles T Lanktree director | AGrant or award Common Stock | +1,132 | $0.00 | $0 | 30,459 | Mar 17, 2025 |
| Dec 14, 2023 | Lloyd Roberts Sams director | AGrant or award Common Stock | +1,071 | $0.00 | $0 | 21,142 | Mar 17, 2025 |
| Dec 14, 2023 | E. Gray Payne director | AGrant or award Common Stock | +1,415 | $0.00 | $0 | 31,791 | Mar 17, 2025 |
| Jan 16, 2025 | Charles T Lanktree director | AGrant or award Stock Option (Right to Buy)derivative | +2,238 | $0.00 | $0 | 2,238 | Mar 17, 2025 |
| Jan 16, 2025 | E. Gray Payne director | AGrant or award Stock Option (Right to Buy)derivative | +2,238 | $0.00 | $0 | 2,238 | Mar 17, 2025 |
| Jan 16, 2025 | Lloyd Roberts Sams director | AGrant or award Stock Option (Right to Buy)derivative | +2,238 | $0.00 | $0 | 2,238 | Mar 17, 2025 |
| Jul 11, 2023 | John M Suzuki CEO & President | AGrant or award Stock Option (Right to Buy)derivative | +10,000 | $0.00 | $0 | 10,000 | Mar 13, 2025 |
| Jun 20, 2024 | Ellen O OHara director | AGrant or award Common Stock | +2,440 | $0.00 | $0 | 2,440 | Feb 20, 2025 |
| Jan 16, 2025 | Ellen O OHara director | AGrant or award Stock Option (Right to Buy)derivative | +2,238 | $0.00 | $0 | 2,238 | Feb 20, 2025 |
| Jan 16, 2025 | Joshua Horowitz director | AGrant or award Stock Option (Right to Buy)derivative | +2,238 | $0.00 | $0 | 2,238 | Feb 18, 2025 |
| Dec 4, 2024 | Charles T Lanktree director | SOpen-market sale Common Stockindirect: By Family | -992 | $35.00 | $35k | 549 | Dec 16, 2024 |
| Dec 13, 2024 | Charles T Lanktree director | SOpen-market sale Common Stockindirect: By Family | -549 | $36.31 | $20k | 0 | Dec 16, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Branko AvanicCTO
- Joshua Horowitzdirector
- Robert Joseph Jacksondirector
- Charles T Lanktreedirector
- Scott A. MalmangerCFO & Secretary
- Ellen O OHaradirector
- E. Gray Paynedirector
- Lloyd Roberts Samsdirector
- John M SuzukiCEO & President
Questions about BKTI
Answered from the filings on this page, as of the latest one.
Are insiders buying BKTI?
No. In the last 90 days no insider at BK Technologies Corp bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade BKTI on the open market?
John M Suzuki (CEO & President) sold $248k of BKTI on Jun 11, 2026 and filed the Form 4 on Jun 12, 2026. InsiderTell scored 38 (weak).
How many insiders file Form 4 at BK Technologies Corp?
9 people have filed a Form 4 at BK Technologies Corp, among them Branko Avanic (CTO), Joshua Horowitz (director), Robert Joseph Jackson (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.